Rifapentine labels and packages

Rifapentine
FDA Package Insert (PRIFTIN®)
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

Labels and Packages

PRINCIPAL DISPLAY PANEL - 150 mg blister NDC 0088-2100-03 Priftin® 150mg rifapentine sanofi-aventis U.S. LLC Peel at unsealed corners DO NOT CUT BLISTER

PRINCIPAL DISPLAY PANEL - 150 mg pouch NDC 0088-2100-03 Priftin® rifapentine 150mg 8 Tablets sanofi-aventis

PRINCIPAL DISPLAY PANEL - 150 mg carton NDC 0088-2100-03 Priftin® rifapentine 150mg 32 Tablets Four 8-Tablet Pouches sanofi-aventis

References

Adapted from the FDA Package Insert.